Work

[The efficacy and safety of low-dose chemotherapy combined with tyrosine kinase inhibitors in the treatment of Philadelphia-chromosomal-positive acute lymphoblastic leukemia].

Year: 2022

Type: other

Abstract: The low-dose chemotherapy is superior to the conventional-dose chemotherapy combined with TKI as induction therapy in Ph(+) ALL with similar efficacy but is safer.

Source: PubMed

DOI: 10.3760/cma.j.issn.0253-2727.2022.07.004

Authors: H Wang, T Zhao, L J Hu, Z R Li, H Jiang, Y Z Qin, Y Y Lai, H X Shi, X J Huang, Q Jiang

Institutions: Peking University, Peking University People's Hospital, Beijing Chuiyangliu Hospital

Language: English

Topic: Acute Lymphoblastic Leukemia research

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W4318449989

Cites: 14

Cited by:

Related to: 10